Get a glimpse into our company and investor data—powered by the PitchBook Platform
Nephromics (U.S. royalty obligation and worldwide diagnostics assets)
Asset Purch.LATEST DEAL TYPE
U.S. royalty obligation and rights of worldwide diagnostics assets of Nephromics. The license is for tests related to the detection, monitoring and risk assessment of preeclampsia, a leading cause of maternal death.